Inventor · disambiguated record
Mark A. Murcko
Also filed as: MURCKO MARK · MURCKO MARK A · MURCKO MARK ANDREW
54 granted patents·19 pending applications·2,362 citations·filing 1994–2024
99Inventor score
Files withVERTEX PHARMA45RELAY THERAPEUTICS INC8DEWPOINT THERAPEUTICS INC6TUNG ROGER D3BATCHELOR MARK JAMES2
Top patents by PatentIndex Score
73 records- 0198US5756466AInhibitors of interleukin-1β converting enzymeVERTEX PHARMA·Filed 1994·Granted May 26, 1998·191 cites·21 claims
- 0297US7772366B2Inhibitors of interleukin-1β converting enzymeVERTEX PHARMA·Filed 2007·Granted Aug 10, 2010·24 cites·10 claims
- 0397US6617309B2Inhibitors of serine proteases, particularly hepatitis C virus NS3 proteaseVERTEX PHARMA·Filed 2001·Granted Sep 9, 2003·103 cites·32 claims
- 0497US6265380B1Inhibitors of serine proteases, particularly hepatitis C virus NS3 proteaseVERTEX PHARMA·Filed 1999·Granted Jul 24, 2001·200 cites·36 claims
- 0596US10934302B1SHP2 phosphatase inhibitors and methods of use thereofRELAY THERAPEUTICS INC·Filed 2020·Granted Mar 2, 2021·44 cites·7 claims
- 0696US7388017B2Inhibitors of serine proteases, particularly hepatitis C virus NS3 proteaseVERTEX PHARMA·Filed 2003·Granted Jun 17, 2008·77 cites·41 claims
- 0796US6372778B1Sulfonamide inhibitors of aspartyl proteaseVERTEX PHARMA·Filed 1995·Granted Apr 16, 2002·142 cites·13 claims
- 0896US5656627AInhibitors of interleukin-1β converting enzymeVERTEX PHARMA·Filed 1995·Granted Aug 12, 1997·146 cites·12 claims
- 0995US7273885B2Inhibitors of serine proteases, particularly HCV NS3-NS4A proteaseVERTEX PHARMA·Filed 2003·Granted Sep 25, 2007·78 cites·29 claims
- 1094US7790713B2Inhibitors of interleukin-1β converting enzymeVERTEX PHARMA·Filed 2007·Granted Sep 7, 2010·24 cites·20 claims
- 1194US7288624B2Inhibitors of interleukin-1β converting enzymeVERTEX PHARMA·Filed 2001·Granted Oct 30, 2007·48 cites·10 claims
- 1294US6531474B1Inhibitors of caspasesVERTEX PHARMA·Filed 2000·Granted Mar 11, 2003·62 cites·15 claims
- 1394US5847135AInhibitors of interleukin-1β converting enzymeVERTEX PHARMA·Filed 1995·Granted Dec 8, 1998·159 cites·11 claims
- 1494US5716929AInhibitors of interleukin-1β converting enzymeVERTEX PHARMA·Filed 1995·Granted Feb 10, 1998·137 cites·59 claims
- 1593US6423840B1Inhibitors of interleukin-1β converting enzymeVERTEX PHARMA·Filed 2001·Granted Jul 23, 2002·40 cites·10 claims
- 1693US5783701ASulfonamide inhibitors of aspartyl proteaseVERTEX PHARMA·Filed 1995·Granted Jul 21, 1998·49 cites·18 claims
- 1792US11340231B2Methods of screening for condensate-associated specificity and uses thereofDEWPOINT THERAPEUTICS INC·Filed 2021·Granted May 24, 2022·6 cites·26 claims
- 1892US6204261B1Inhibitors of interleukin-1β Converting enzyme inhibitorsVERTEX PHARMA·Filed 1996·Granted Mar 20, 2001·80 cites·34 claims
- 1992US5874424AInhibitors of interleukin-1β converting enzymeVERTEX PHARMA·Filed 1996·Granted Feb 23, 1999·141 cites·7 claims
- 2091US12084447B2SHP2 phosphatase inhibitors and methods of use thereofRELAY THERAPEUTICS INC·Filed 2020·Granted Sep 10, 2024·2 cites·20 claims
- 2191US11493519B2Methods of characterizing condensate-associated characteristics of compounds and uses thereofDEWPOINT THERAPEUTICS INC·Filed 2020·Granted Nov 8, 2022·4 cites·36 claims
- 2291US8119631B2Inhibitors of interleukin-1β converting enzymeBATCHELOR MARK JAMES·Filed 2010·Granted Feb 21, 2012·24 cites·15 claims
- 2391US6103711AInhibitors of interleukin-1β converting enzymeVERTEX PHARMA·Filed 1995·Granted Aug 15, 2000·80 cites·13 claims
- 2491US5973111AInhibitors of interleukin-1β converting enzymeVERTEX PHARMA·Filed 1997·Granted Oct 26, 1999·91 cites·14 claims
- 2590US6420522B1Inhibitors of interleukin-1β converting enzymeVERTEX PHARMA·Filed 1999·Granted Jul 16, 2002·72 cites·10 claims
- 2687US7365072B2Inhibitors of p38VERTEX PHARMA·Filed 2005·Granted Apr 29, 2008·7 cites·23 claims
- 2787US6025147AInhibitors of interleukin-1 β converting enzymeVERTEX PHARMA·Filed 1995·Granted Feb 15, 2000·57 cites·2 claims
- 2886US12174198B2Methods of characterizing condensate-associated characteristics of compounds and uses thereofDEWPOINT THERAPEUTICS INC·Filed 2022·Granted Dec 24, 2024·1 cites·17 claims
- 2986US11701354B2Pyrazolo[3,4-b]pyrazine derivatives as SHP2 phosphatase inhibitorsRELAY THERAPEUTICS INC·Filed 2018·Granted Jul 18, 2023·3 cites·40 claims
- 3086US5977137ASulfonamide inhibitors of aspartyl proteaseVERTEX PHARMA·Filed 1998·Granted Nov 2, 1999·26 cites·21 claims
- 3185US11591336B2Substituted pyrazolo[3,4-b]pyrazines as SHP2 phosphatase inhibitorsRELAY THERAPEUTICS INC·Filed 2018·Granted Feb 28, 2023·3 cites·54 claims
- 3285US6258948B1Inhibitors of Interleukin-1β converting enzymeVERTEX PHARMA·Filed 1999·Granted Jul 10, 2001·42 cites·46 claims
- 3382US8314141B2Inhibitors of serine proteases, particularly hepatitis C virus NS3 proteaseTUNG ROGER D·Filed 2008·Granted Nov 20, 2012·3 cites·9 claims
- 3482US5843904AInhibitors of interleukin-1βconverting enzymeVERTEX PHARMA·Filed 1995·Granted Dec 1, 1998·51 cites·19 claims
- 3581US11629145B2SHP2 phosphatase inhibitors and methods of use thereofRELAY THERAPEUTICS INC·Filed 2017·Granted Apr 18, 2023·3 cites·18 claims
- 3681US5856353ASulfonamide inhibitors of aspartyl proteaseVERTEX PHARMA·Filed 1995·Granted Jan 5, 1999·33 cites·20 claims
- 3780US7205305B2Inhibitors of p38VERTEX PHARMA·Filed 2003·Granted Apr 17, 2007·9 cites·19 claims
- 3878US12331056B2SHP2 phosphatase inhibitors and methods of use thereofRELAY THERAPEUTICS INC·Filed 2022·Granted Jun 17, 2025·0 cites·21 claims
- 3978US2025298031A1Methods of characterizing condensate-associated characteristics of compounds and uses thereofDEWPOINT THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 4076US8691848B2Inhibitors of caspasesWANNAMAKER MARION W·Filed 2008·Granted Apr 8, 2014·2 cites·17 claims
- 4176US7608632B2Sulfonamide inhibitors of aspartyl proteaseVERTEX PHARMA·Filed 2006·Granted Oct 27, 2009·1 cites·6 claims
- 4275US8338412B2Inhibitors of P38BEMIS GUY W·Filed 2011·Granted Dec 25, 2012·3 cites·19 claims
- 4374US6974809B2Inhibitors of interleukin 1-β converting enzymeVERTEX PHARMA·Filed 2003·Granted Dec 13, 2005·5 cites·13 claims
- 4474US6127372ASulfonamide inhibitors of aspartyl proteaseVERTEX PHARMA·Filed 1995·Granted Oct 3, 2000·19 cites·23 claims
- 4573US7358273B2Inhibitors of caspasesVERTEX PHARMA·Filed 2002·Granted Apr 15, 2008·5 cites·15 claims
- 4671US6008217AInhibitors of interleukin-1β converting enzymeVERTEX PHARMA·Filed 1995·Granted Dec 28, 1999·37 cites·30 claims
- 4770US2010210603A1Novel sulfonamide inhibitors of aspartyl proteaseTUNG ROGER D·Filed 2009·Application pending·0 cites
- 4869US6573259B2Inhibitors of interleukin-1β converting enzymeVERTEX PHARMA·Filed 2001·Granted Jun 3, 2003·3 cites·15 claims
- 4967US12422437B2Methods of screening for condensate-associated specificity and uses thereofDEWPOINT THERAPEUTICS INC·Filed 2022·Granted Sep 23, 2025·0 cites·27 claims
- 5066US7951809B2Inhibitors of p38VERTEX PHARMA·Filed 2008·Granted May 31, 2011·0 cites·14 claims
Showing the top 50 of 73 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →